4//SEC Filing
Lee Jeffrey Gene 4
Accession 0000899243-23-003412
CIK 0001314966other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 4:17 PM ET
Size
14.0 KB
Accession
0000899243-23-003412
Insider Transaction Report
Form 4
Lee Jeffrey Gene
Other
Transactions
- Exercise/Conversion
Phantom Shares
2023-01-31−128.724→ 257.448 total→ Common Stock (128.724 underlying) - Disposition to Issuer
Common Stock
2023-01-31$43.56/sh−204.568$8,911→ 0 total - Award
Phantom Shares
2023-01-31$43.56/sh+83.29$3,628→ 83.29 total→ Common Stock (83.29 underlying) - Exercise/Conversion
Phantom Shares
2023-01-31−75.844→ 75.844 total→ Common Stock (75.844 underlying) - Exercise/Conversion
Common Stock
2023-01-31+204.568→ 204.568 total
Footnotes (4)
- [F1]A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash.
- [F2]As previously reported on a Form 4 dated February 2, 2022, the Reporting Person was granted phantom shares on January 31, 2022 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date.
- [F3]As previously reported on a Form 4 dated February 2, 2021, the Reporting Person was granted phantom shares on January 29, 2021 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date.
- [F4]These phantom shares vest in equal installments on each of the first three anniversaries of the award.
Documents
Issuer
BlackRock Health Sciences Trust
CIK 0001314966
Entity typeother
Related Parties
1- filerCIK 0001815443
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 4:17 PM ET
- Size
- 14.0 KB